Therapeutic Antibodies Targeting CSF1 Impede Macrophage Recruitment in a Xenograft Model of Tenosynovial Giant Cell Tumor
Figure 2
Effect of CSF1 inhibitors on macrophage infiltration in PVNS xenografts. (a) Data from experiments using eight individual patient tumors (host macrophages counted after 2 weeks of the indicated treatments). Error bars represent the confidence interval of the observed median. In case number eight, the dose of imatinib was doubled to but showed similar effects. () denotes cases where imatinib was not given.
